Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23532425 | 1.00 | KDM1A (0.31) | KDM1AALDH1A1CYP3A4CXCR3HDAC4 | |
| SCHEMBL6291549 | 1.00 | KDM1A (0.31) | KDM1AALDH1A1CYP3A4CXCR3HDAC4 | |
| SCHEMBL6291550 | 1.00 | KDM1A (0.31) | KDM1AALDH1A1CYP3A4CXCR3HDAC4 | |
| SCHEMBL23532623 | 1.00 | KDM1A (0.31) | KDM1AALDH1A1CYP3A4CXCR3HDAC4 | |
| SCHEMBL1640058 | 0.97 | KDM1A (0.32) | KDM1AALDH1A1CYP3A4HDAC4HDAC2 | |
| SCHEMBL335949 | 0.90 | — | — | |
| SCHEMBL17241764 | 0.81 | — | — | |
| SCHEMBL7125955 | 0.79 | KDM1A (0.33) | KDM1AHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL4272346 | 0.78 | KDM1A (0.30) | KDM1AALDH1A1CYP3A4 | |
| SCHEMBL299770 | 0.78 | KDM1A (0.30) | KDM1AALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4413085-A1 | SILICON-AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES | Arkema, Inc. (US) | 2024-08-14 | — | — | EP | claimed |
| CN-118318010-A | Coupling agents containing silicon and zinc for cellulosic material-polymer composites | 阿科玛股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| WO-2023059592-A1 | SILICON-AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES | ARKEMA INC. (US) | 2023-04-13 | — | — | WO | claimed |
| US-20220056275-A1 | SILICON- AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES | ARKEMA INC. | 2022-02-24 | — | — | US | claimed |
| EP-4413085-A1 | SILICON-AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES | Arkema, Inc. (US) | 2024-08-14 | — | — | EP | disclosed |
| CN-118318010-A | Coupling agents containing silicon and zinc for cellulosic material-polymer composites | 阿科玛股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2023059592-A1 | SILICON-AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES | ARKEMA INC. (US) | 2023-04-13 | — | — | WO | disclosed |
| US-20230051031-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2023-02-16 | — | — | US | disclosed |
| US-20230034883-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (60%) (IT) | 2023-02-02 | — | — | US | disclosed |
| EP-4076729-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | Consiglio Nazionale Delle Ricerche (IT) | 2022-10-26 | — | — | EP | disclosed |
| EP-4076730-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | Consiglio Nazionale Delle Ricerche (IT) | 2022-10-26 | — | — | EP | disclosed |
| US-20220056275-A1 | SILICON- AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES | ARKEMA INC. | 2022-02-24 | — | — | US | disclosed |
| WO-2021124097-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON SEPIOLITE FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021124103-A1 | MULTI-FUNCTIONAL HYBRID MATERIAL BASED ON NATURAL CLAYS FOR ENVIRONMENTAL RECOVERY AND BIO-REMEDIATION | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2021-06-24 | — | — | WO | disclosed |
| US-6951942-B2 | Glucocorticoid-selective anti-inflammatory agents | ABBOTT LABORATORIES (US) | 2005-10-04 | — | — | US | disclosed |
| US-20030073703-A1 | Glucocortiocoid-selective antinflammatory agents | ABBOTT LABORATORIES AND LIGAND PHARMACEUTICALS INCORPORATED | 2003-04-17 | — | — | US | disclosed |
| EP-1299392-A2 | GLUCOCORTIOCOID-SELECTIVE ANTIINFLAMMATORY AGENTS | Abbott Laboratories (US) | 2003-04-09 | — | — | EP | disclosed |
| US-6506766-B1 | A pharmaceutical composition for use in treating inflammation, immune, autoimmune, and inflammatory diseases in a mammal by selectively modulating the activation, repression, agonism, and antagonism effects of the mammal's glucocorticoid | ABBOTT LABORATORIES | 2003-01-14 | — | — | US | disclosed |
| EP-1053239-B1 | GLUCOCORTICOID-SELECTIVE ANTI-INFLAMMATORY AGENTS | ABBOTT LAB (US) | 2003-01-08 | — | — | EP | disclosed |
| WO-2002002565-A2 | GLUCOCORTIOCOID-SELECTIVE ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES (US) | 2002-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073703-A1 | Glucocortiocoid-selective antinflammatory agents | NR3C1, GPR119, MC2R | KDM1A 3861/4885ALDH1A1 3187/4885CYP3A4 4325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.